Company Filing History:
Years Active: 2023
Title: Frances Weis-Garcia: Innovator in Antibody Research
Introduction
Frances Weis-Garcia is a prominent inventor based in New York, NY (US). She has made significant contributions to the field of antibody research, particularly in the development of anti-CD20 antibodies. Her work has implications for both treatment and diagnosis in various medical conditions.
Latest Patents
Frances Weis-Garcia holds a patent for an "Anti-CD20 antibody and uses thereof." This patent provides details on anti-CD20 antibodies and their applications in treatment and diagnosis. Additionally, it includes information on CD20 antigens that are essential for the production of these antibodies, as well as methods for generating anti-CD20 antibodies using the CD20 antigens.
Career Highlights
Frances Weis-Garcia is affiliated with the Memorial Sloan Kettering Cancer Center, where she continues her research and development efforts. Her work is recognized for its potential impact on cancer treatment and diagnostics.
Collaborations
Frances has collaborated with notable colleagues, including Isabelle Riviere and Ouathek Ouerfelli. These collaborations enhance the research environment and contribute to advancements in the field.
Conclusion
Frances Weis-Garcia is a key figure in the development of anti-CD20 antibodies, with a patent that underscores her innovative contributions to medical research. Her work at Memorial Sloan Kettering Cancer Center exemplifies the importance of collaboration in advancing healthcare solutions.